Clinical and Pathophysiologic Aspects of ECMO-associated hemorrhagic complications RESEARCH ARTICLE Clinical and pathophysiologic aspects ofECMO-associated hemorrhagic complications Konstantin A. PopugaevID1,2*, Sergey A. Bakharev2, Kirill V. Kiselev3, AlexanderS. Samoylov2, Nikolay M. Kruglykov2, Sergey A. Abudeev1, Sergey V. Zhuravel1, Aslan K. Shabanov1, Thomas Mueller4, Stephan A. Mayer5, Sergey S. Petrikov11 Department of Intensive Care, Sklifosovsky Research Institute […]
Does the use of extracorporeal membrane oxygenation (ECMO) improve their outcome in the CVICU (I) compared to non-ECMO interventions (C) affect their survival rate (O) during hospitalization? (T).
PICOT Question: In patients 30-60 years of age, with acute respiratory distress syndrome caused by COVID 19 (P), does the use of extracorporeal membrane oxygenation (ECMO) improve their outcome in the CVICU (I) compared to non-ECMO interventions (C) affect their survival rate (O) during hospitalization (T).